Benzinga - by Avi Kapoor, Benzinga Staff Writer.
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Thursday.
The Dow traded up 0.06% to 37,829.32 while the NASDAQ rose 0.22% to 15,515.62. The S&P 500 also rose, gaining, 0.26% to 4,881.28.
Check This Out: How To Earn $500 A Month From Capital One Financial Ahead Of Its Q4 Earnings Report
Leading and Lagging Sectors
Communication services shares rose by 1.5% on Thursday.
In trading on Thursday, consumer discretionary shares fell by 1.4%.
Top Headline
Tesla, Inc. (NASDAQ: TSLA) shares dipped more than 12% on Thursday after the company reported worse-than-expected fourth-quarter financial results.
Tesla reported fourth-quarter revenue of $25.17 billion, which was up 3% year-over-year. The revenue missed a Street consensus estimate of $25.62 billion, according to data from Benzinga Pro. The company reported earnings per share of 71 cents, which missed a Street consensus estimate of 74 cents per share.
Equities Trading UP
Vera Therapeutics, Inc. (NASDAQ: VERA) shares shot up 40% to $23.87 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target.
Shares of Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) got a boost, surging 120% to $4.5150 after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine.
LAVA Therapeutics N.V. (NASDAQ: LVTX) shares were also up, gaining 38% to $2.1401 after the company announced a clinical trial collaboration and supply agreement with Merck & Co. to evaluate LAVA-1207 in conbination with KEYTRUDA.
Equities Trading DOWN
RedHill Biopharma Ltd. (NASDAQ: RDHL) shares dropped 47% to $0.5680 after the company announced an $8 million registered direct offering.
Shares of Akoustis Technologies, Inc. (NASDAQ: AKTS) were down 23% to $0.5401 after the company announced pricing of a public offering of $10 million of common stock.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) was down, falling 20% to $0.2354.
Intelligent Bio Solutions reported a 1-for-12 reverse stock split.
Also Check This Out: Visa Gears Up For Q4 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Commodities
In commodity news, oil traded up 2% to $76.60 while gold traded down 0.1% at $2,013.50.
Silver traded down 0.15% to $22.855 on Thursday while copper fell 0.5% to $3.8670.
Euro zone
European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.30%, London’s FTSE 100 rose 0.03% while Spain’s IBEX 35 Index fell 0.58% The German DAX rose 0.10% French CAC 40 rose 0.11% while Italy’s FTSE MIB Index fell 0.60%.
The European Central Bank kept interest rates unchanged during its recent meeting. The Ifo Business Climate indicator for Germany declined to 85.2 in January versus a revised reading of 86.3 in the prior month. Producer prices in Spain fell by 6.3% year-over-year in December, while manufacturing climate indicator in France came in unchanged at 99 for January.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan’s Nikkei 225 gaining 0.03%, Hong Kong’s Hang Seng Index climbing 1.96% and China’s Shanghai Composite Index gaining 3.03%. India’s S&P BSE Sensex, meanwhile, fell 0.51%.
Imports to Hong Kong jumped by 11.6% year-over-year to $446.3 billion in December, while exports from Hong Kong rose 11% year-over-year to $386.4 billion.
Economics
The US economy grew an annualized 3.3% in the fourth quarter, versus market estimates of a 2% rise, and compared to a 4.9% rate in the prior quarter.
U.S. initial jobless claims increased by 25,000 to 214,000 in the week ending Jan. 20.
The US trade deficit in goods narrowed to $88.5 billion in December versus a revised $89.3 billion in the prior month.
The Chicago Fed National Activity Index declined to -0.15 in December versus a revised 0.01 in the previous month.
Wholesale inventories in the U.S. increased by 0.4% month-over-month in December.
New orders for manufactured durable goods in the U.S. came in unchanged for December.
U.S. natural-gas supplies fell 326 billion cubic during the week ended Jan. 19, 2024, the EIA said.
Now Read This: Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.